204 related articles for article (PubMed ID: 25326455)
1. Ageing and muscular dystrophy differentially affect murine pharyngeal muscles in a region-dependent manner.
Randolph ME; Luo Q; Ho J; Vest KE; Sokoloff AJ; Pavlath GK
J Physiol; 2014 Dec; 592(23):5301-15. PubMed ID: 25326455
[TBL] [Abstract][Full Text] [Related]
2. Myopathy phenotype in transgenic mice expressing mutated PABPN1 as a model of oculopharyngeal muscular dystrophy.
Hino H; Araki K; Uyama E; Takeya M; Araki M; Yoshinobu K; Miike K; Kawazoe Y; Maeda Y; Uchino M; Yamamura K
Hum Mol Genet; 2004 Jan; 13(2):181-90. PubMed ID: 14645203
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial localization of PABPN1 in oculopharyngeal muscular dystrophy.
Doki T; Yamashita S; Wei FY; Hara K; Yamamoto T; Zhang Z; Zhang X; Tawara N; Hino H; Uyama E; Kurashige T; Maruyama H; Tomizawa K; Ando Y
Lab Invest; 2019 Nov; 99(11):1728-1740. PubMed ID: 30894671
[TBL] [Abstract][Full Text] [Related]
4. A study of impairments in oculopharyngeal muscular dystrophy.
Brisson JD; Gagnon C; Brais B; Côté I; Mathieu J
Muscle Nerve; 2020 Aug; 62(2):201-207. PubMed ID: 32270505
[TBL] [Abstract][Full Text] [Related]
5. Nuclear speckles are involved in nuclear aggregation of PABPN1 and in the pathophysiology of oculopharyngeal muscular dystrophy.
Bengoechea R; Tapia O; Casafont I; Berciano J; Lafarga M; Berciano MT
Neurobiol Dis; 2012 Apr; 46(1):118-29. PubMed ID: 22249111
[TBL] [Abstract][Full Text] [Related]
6. Comparative evolution of muscular dystrophy in diaphragm, gastrocnemius and masseter muscles from old male mdx mice.
Muller J; Vayssiere N; Royuela M; Leger ME; Muller A; Bacou F; Pons F; Hugon G; Mornet D
J Muscle Res Cell Motil; 2001; 22(2):133-9. PubMed ID: 11519736
[TBL] [Abstract][Full Text] [Related]
7. Modeling oculopharyngeal muscular dystrophy in myotube cultures reveals reduced accumulation of soluble mutant PABPN1 protein.
Raz V; Routledge S; Venema A; Buijze H; van der Wal E; Anvar S; Straasheijm KR; Klooster R; Antoniou M; van der Maarel SM
Am J Pathol; 2011 Oct; 179(4):1988-2000. PubMed ID: 21854744
[TBL] [Abstract][Full Text] [Related]
8. Atrophy, fibrosis, and increased PAX7-positive cells in pharyngeal muscles of oculopharyngeal muscular dystrophy patients.
Gidaro T; Negroni E; Perié S; Mirabella M; Lainé J; Lacau St Guily J; Butler-Browne G; Mouly V; Trollet C
J Neuropathol Exp Neurol; 2013 Mar; 72(3):234-43. PubMed ID: 23399899
[TBL] [Abstract][Full Text] [Related]
9. Late onset oculopharyngeal muscular dystrophy with prominent neurogenic features and short GCG trinucleotide expansion.
Piccolo G; Cortese A; Tavazzi E; Piccolo L; Sassone J; Ciammola A; Alfonsi E; Colombo I; Moggio M
Muscle Nerve; 2011 Jan; 43(1):141-2. PubMed ID: 21171103
[No Abstract] [Full Text] [Related]
10. PABPN1 gene therapy for oculopharyngeal muscular dystrophy.
Malerba A; Klein P; Bachtarzi H; Jarmin SA; Cordova G; Ferry A; Strings V; Espinoza MP; Mamchaoui K; Blumen SC; St Guily JL; Mouly V; Graham M; Butler-Browne G; Suhy DA; Trollet C; Dickson G
Nat Commun; 2017 Mar; 8():14848. PubMed ID: 28361972
[TBL] [Abstract][Full Text] [Related]
11. The clinical and myopathological features of oculopharyngodistal myopathy in a Chinese family.
Lu H; Luan X; Yuan Y; Dong M; Sun W; Yan C
Neuropathology; 2008 Dec; 28(6):599-603. PubMed ID: 18503509
[TBL] [Abstract][Full Text] [Related]
12. Over-expression of BCL2 rescues muscle weakness in a mouse model of oculopharyngeal muscular dystrophy.
Davies JE; Rubinsztein DC
Hum Mol Genet; 2011 Mar; 20(6):1154-63. PubMed ID: 21199860
[TBL] [Abstract][Full Text] [Related]
13. Altered pharyngeal muscles in Parkinson disease.
Mu L; Sobotka S; Chen J; Su H; Sanders I; Adler CH; Shill HA; Caviness JN; Samanta JE; Beach TG;
J Neuropathol Exp Neurol; 2012 Jun; 71(6):520-30. PubMed ID: 22588389
[TBL] [Abstract][Full Text] [Related]
14. Oculopharyngeal muscular dystrophy: a polyalanine myopathy.
Brais B
Curr Neurol Neurosci Rep; 2009 Jan; 9(1):76-82. PubMed ID: 19080757
[TBL] [Abstract][Full Text] [Related]
15. Oculopharyngeal muscular dystrophy: underdiagnosed disease in Hong Kong.
Luk HM; Lo IF; Fu KH; Lui CH; Tong TM; Chan DH; Lam ST
Hong Kong Med J; 2013 Dec; 19(6):556-9. PubMed ID: 24310666
[TBL] [Abstract][Full Text] [Related]
16. Intranuclear Aggregates Precede Clinical Onset in Oculopharyngeal Muscular Dystrophy.
van der Sluijs BM; Raz V; Lammens M; van den Heuvel LP; Voermans NC; van Engelen BG
J Neuromuscul Dis; 2016 Mar; 3(1):101-109. PubMed ID: 27854203
[TBL] [Abstract][Full Text] [Related]
17. Post-transcriptional regulation of Pabpn1 by the RNA binding protein HuR.
Phillips BL; Banerjee A; Sanchez BJ; Di Marco S; Gallouzi IE; Pavlath GK; Corbett AH
Nucleic Acids Res; 2018 Sep; 46(15):7643-7661. PubMed ID: 29939290
[TBL] [Abstract][Full Text] [Related]
18. [Preferential distal muscle involvement in case of oculopharyngeal muscular dystrophy with (GCG) 13 expansion].
Nakashima D; Nakajima H; Ishida S; Sugino M; Kimura F; Hanafusa T
Rinsho Shinkeigaku; 2003 Sep; 43(9):560-3. PubMed ID: 14727564
[TBL] [Abstract][Full Text] [Related]
19. Swallow characteristics in patients with oculopharyngeal muscular dystrophy.
Palmer PM; Neel AT; Sprouls G; Morrison L
J Speech Lang Hear Res; 2010 Dec; 53(6):1567-78. PubMed ID: 20699340
[TBL] [Abstract][Full Text] [Related]
20. Functional impact of an oculopharyngeal muscular dystrophy mutation in PABPN1.
García-Castañeda M; Vega AV; Rodríguez R; Montiel-Jaen MG; Cisneros B; Zarain-Herzberg A; Avila G
J Physiol; 2017 Jul; 595(13):4167-4187. PubMed ID: 28303574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
